A detailed history of Clearstead Advisors, LLC transactions in Conmed Corp stock. As of the latest transaction made, Clearstead Advisors, LLC holds 2,591 shares of CNMD stock, worth $182,302. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,591
Previous 2,591 -0.0%
Holding current value
$182,302
Previous $179,000 3.91%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$61.9 - $80.36 $157,411 - $204,355
2,543 Added 5297.92%
2,591 $179,000
Q4 2023

Feb 12, 2024

BUY
$91.3 - $115.05 $2,008 - $2,531
22 Added 84.62%
48 $5,000
Q3 2023

Nov 07, 2023

BUY
$97.55 - $135.91 $2,536 - $3,533
26 New
26 $2,000

Others Institutions Holding CNMD

About CONMED Corp


  • Ticker CNMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 30,482,400
  • Market Cap $2.14B
  • Description
  • CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...
More about CNMD
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.